Triple ISBER Honors For Brooks Life Sciences

Brooks Life Sciences is a division of Brooks Automation that has a most comprehensive portfolio of sample management solutions for the life sciences industry, enabling accelerated innovations by researchers worldwide to improve patient health. On offer are automated storage...

Biobanking Science: Using FTA Cards to Preserve Nucleic Acids

Biobanking organizations may use a range of different methods to preserve biological samples including cryopreservation, fixation and paraffin-embedding and FTA cards. Biobanking Samples by Cryopreservation Cryopreservation remains the gold standard for long-term biobanking because this method maintains the integrity and biological...

The National Biosample Centre (NBC) UK

The National Biosample Centre (NBC) is operated by the UK Biocentre as a not-for-profit organisation and was established by the National Institute for Health Research (NIHR) in the UK. The National Biosample Centre makes extensive use of software and...

Thinking Big At The ISBER 2018 Biobanking Meeting

The International Society for Biological and Environmental Repositories (ISBER) mission is to create opportunities for networking, education, and innovations for the global biobanking community. It actively harmonizes approaches to the challenges of biological and environmental repositories. The organisation hosted...

10 Largest Biobanks in the World

Disclaimer: This article is not intended to be definitive. It was sourced from freely, openly available information on the internet. Due to the vastness of the World Wide Web, and evolving algorithms that prioritize web pages in search results,...
Biobanking is an essential part of developing new cell therapies.

Biobanking Science: Perinatal Cell Therapies

Biobanking is an Integral Part of Cell Therapy Cell therapy is a rapidly growing medical field with the potential to treat a wide range of human diseases. Cell therapies comprise living cells which presents a unique biobanking challenge. The biological...

StemBioSys Raises $4.3M For New Products

StemBioSys has closed a $4.3 million Series B round of funding roughly two years after it began fundraising. The company spent much of 2017 launching new branding for its lead product which is now called CELLvo™ Matrix, which is...

Cesca Therapeutics’ CTO Talks CAR-T Manufacturing

Cesca Therapeutics Inc. is in the business of developing, commercializing and marketing a range of automated technologies for CAR-T and other cell-based therapies. The device division, ThermoGenesis Corp., provides a full suite of solutions for automated clinical biobanking, point-of-care...

Cytox To Make Use Of Mayo Clinic’s Alzheimer’s Biobank

Cytox is a precision medicine company with a focus on neurodegenerative disorders such as Alzheimer’s disease. The Cytox scientific and proprietary technology platform is being applied to the prediction of cognitive decline and neurodegenerative disorder risk. The Mayo Clinic is...

California Cryobank Stem Cell Services LLC Has Acquired Cord Blood America Inc

California Cryobank Stem Cell Services LLC ("FamilyCord"), has recently acquired Cord Blood America Inc. ("CBAI"), joining two of the industry's most respected stem cell companies. FamilyCord will maintain the long-term cryogenic storage of the stem cell units in its...